DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Adams S, Diamond JR, Hamilton E. et al.
Atezolizumab plus nab-paclitaxel in the treatment of metastatic triple-negative breast cancer with 2-year survival follow-up: A phase 1b clinical trial.
JAMA Oncol 2018;
DOI: 10.1001/jamaoncol.2018.5152.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.